Codexis (CDXS) Operating Expenses (2010 - 2026)
Codexis (CDXS) posted quarterly Operating Expenses of $23.3 million for Q1 2026, down 16.9% year-over-year from $28.0 million in Q1 2025, and down 17.86% quarter-over-quarter from $28.4 million in Q4 2025.
Codexis (CDXS) Operating Expenses (2010 - 2026) Analysis & Trends
Codexis' Operating Expenses history runs 17 years deep, the most recent figure standing at $23.3 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 16.9% year-over-year to $23.3 million; the TTM figure through Mar 2026 stood at $107.4 million (down 8.16% YoY), while the FY2025 annual figure was $112.1 million, down 4.87% from the prior year.
- Operating Expenses for Q1 2026 stood at $23.3 million, down from $28.4 million in the prior quarter.
- The five-year high for Operating Expenses was $45.1 million in Q3 2022, with the low at $23.3 million in Q1 2026.
- The 5-year median for Operating Expenses is $29.4 million (2024), against an average of $33.2 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 60.83% in 2022, then slumped 39.76% in 2023.
- Codexis' Operating Expenses stood at $43.6 million in 2022, then plunged by 39.76% to $26.3 million in 2023, then rose by 9.59% to $28.8 million in 2024, then slipped by 1.55% to $28.4 million in 2025, then decreased by 17.86% to $23.3 million in 2026.
- Business Quant data shows CDXS's Operating Expenses at $23.3 million in Q1 2026, $28.4 million in Q4 2025, and $27.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Codexis | 143.86 Mn | 88.95 Mn | 11.40 Mn | 26.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.14 Mn |
| Mar 31, 2026 | 23.29 Mn |
| Dec 31, 2025 | 28.36 Mn |
| Sep 30, 2025 | 27.55 Mn |
| Jun 30, 2025 | 28.19 Mn |
| Mar 31, 2025 | 28.03 Mn |
| Dec 31, 2024 | 28.80 Mn |
| Sep 30, 2024 | 29.39 Mn |
| Jun 30, 2024 | 30.71 Mn |
| Mar 31, 2024 | 28.96 Mn |
| Dec 31, 2023 | 26.28 Mn |
| Sep 30, 2023 | 41.34 Mn |
| Jun 30, 2023 | 33.95 Mn |
| Mar 31, 2023 | 36.65 Mn |
| Dec 31, 2022 | 43.63 Mn |
| Sep 30, 2022 | 45.11 Mn |
| Jun 30, 2022 | 41.02 Mn |
| Mar 31, 2022 | 43.73 Mn |
| Dec 31, 2021 | 34.89 Mn |
| Sep 30, 2021 | 35.44 Mn |